TY - JOUR
T1 - Primary ciliary dyskinesia
T2 - Recent advances in pathogenesis, diagnosis and treatment
AU - Lie, Hauw
AU - Ferkol, Thomas
N1 - Funding Information:
The authors would like to thank Dr Steve Brody, Dr Frances White and Dr John Carson for the images used in this manuscript. Dr Ferkol is a member of the National Institutes of Health (NIH) Genetic Disorders of Mucociliary Clearance Consortium, and his work on primary ciliary dyskinesia is supported by NIH grant awards RR019480 and HL079024. Dr Ferkol is currently a member of a speakers bureau sponsored by Novartis Corporation. Dr Lie has no conflicts of interest that are directly relevant to the contents of this review. No sources of funding were used to assist in the preparation of this review.
PY - 2007
Y1 - 2007
N2 - Primary ciliary dyskinesia is a genetic disorder causing dysfunctional motility of cilia and impaired mucociliary clearance, resulting in a myriad of clinical manifestations including recurrent sinopulmonary disease, laterality defects and infertility. The heterogenous clinical presentation of primary ciliary dyskinesia and the limitations of transmission electron microscopy to assess ultrastructural defects within the cilium often delay diagnosis. Recent advances in the understanding of the basic biology and function of the cilium have led to potential diagnostic alternatives, including ciliary beat analysis and nasal nitric oxide measurements. Moreover, the identification of disease-causing mutations could lead to the development of comprehensive genetic testing that may overcome many of the current diagnostic limitations. Although the clinical manifestations of primary ciliary dyskinesia have been recognised for over a century, there are few studies examining treatments and standards of care have yet to be established. Multicentre collaborative efforts have been established in North America and Europe, which should help to develop standardised approaches to the diagnosis and treatment of primary ciliary dyskinesia.
AB - Primary ciliary dyskinesia is a genetic disorder causing dysfunctional motility of cilia and impaired mucociliary clearance, resulting in a myriad of clinical manifestations including recurrent sinopulmonary disease, laterality defects and infertility. The heterogenous clinical presentation of primary ciliary dyskinesia and the limitations of transmission electron microscopy to assess ultrastructural defects within the cilium often delay diagnosis. Recent advances in the understanding of the basic biology and function of the cilium have led to potential diagnostic alternatives, including ciliary beat analysis and nasal nitric oxide measurements. Moreover, the identification of disease-causing mutations could lead to the development of comprehensive genetic testing that may overcome many of the current diagnostic limitations. Although the clinical manifestations of primary ciliary dyskinesia have been recognised for over a century, there are few studies examining treatments and standards of care have yet to be established. Multicentre collaborative efforts have been established in North America and Europe, which should help to develop standardised approaches to the diagnosis and treatment of primary ciliary dyskinesia.
UR - http://www.scopus.com/inward/record.url?scp=34548341829&partnerID=8YFLogxK
U2 - 10.2165/00003495-200767130-00006
DO - 10.2165/00003495-200767130-00006
M3 - Review article
C2 - 17722956
AN - SCOPUS:34548341829
SN - 0012-6667
VL - 67
SP - 1883
EP - 1892
JO - Drugs
JF - Drugs
IS - 13
ER -